신경중재영상의학 시장 규모, 점유율, 성장 분석 : 구성요소별, 병태별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Interventional Neuroradiology Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.36 Billion in 2025 to USD 14.56 Billion by 2033, growing at a CAGR of 20.1% during the forecast period (2026-2033).

The global interventional neuroradiology market is increasingly vital due to its minimally invasive solutions for cerebrovascular disorders, offering alternatives to open surgery. As the incidence of conditions like strokes, intracranial aneurysms, and arteriovenous malformations rises, effective and timely management becomes critical to reducing morbidity and healthcare costs. The growth of this market is significantly fueled by improved reimbursement policies, which alleviate financial pressures on hospitals and patients, increasing procedure rates. Recognition by insurers of the cost-effectiveness of endovascular treatments fosters wider coverage for essential devices. Also, advancements in AI and IoT are enhancing patient safety, enabling real-time data analysis, and predictive warnings for potential complications, streamlining procedures, and boosting confidence in high-stakes neurovascular interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Neuroradiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Neuroradiology Market Segments Analysis

The global interventional neuroradiology market is segmented by component, pathology type, end user and region. Based on component, the market is segmented into Embolization Devices, Neurothrombectomy Devices, Support Devices, Access Devices and Software as a Service Platforms. Based on pathology type, the market is segmented into Intracranial Aneurysms, Arteriovenous Malformations, Acute Ischemic Stroke and Carotid Artery Disease. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Interventional Neuroradiology Market

The increasing desire for minimally invasive therapeutic options is fueling the growth of the interventional neuroradiology market. Patients and healthcare professionals alike are advocating for procedures that minimize hospital stays, lower the risks of complications, and facilitate quicker recovery times. Innovations in catheter technology coupled with advanced imaging techniques enable accurate navigation within cerebral vessels, making previously complex aneurysm and stroke treatments feasible in an outpatient setting. This clinical advantage not only promotes wider adoption across various medical specialties but also boosts procedural volumes, prompting companies to invest in specialized neuro-intervention facilities that further accelerate market expansion. As perceived outcomes improve, referral rates rise, leading institutions to establish dedicated neuro-intervention units.

Restraints in the Global Interventional Neuroradiology Market

The Global Interventional Neuroradiology market faces significant challenges due to the substantial initial investment required for specialized angiography suites, robotic assistance, and high-definition imaging equipment. Smaller clinics and hospitals in developing regions often struggle to implement interventional neuroradiology programs due to limited financing options and extended payback periods, creating financial strain. As a result, administrators frequently opt for more cost-effective services, impeding market penetration in budget-constrained areas despite persistent clinical demand and technological advancements. Consequently, many institutions postpone upgrades to existing catheterization labs, choosing conventional surgical methods that necessitate less upfront capital investment instead.

Market Trends of the Global Interventional Neuroradiology Market

The Global Interventional Neuroradiology market is witnessing a significant transformation driven by the integration of AI-driven imaging technologies. By enhancing the speed and accuracy of image processing, these advancements facilitate immediate lesion detection and precise catheter navigation, while simultaneously minimizing radiation exposure-a critical concern in the field. Clinicians increasingly leverage deep learning models to refine procedure planning and customize treatment strategies, fostering a more predictive approach to patient care. This trend is also promoting a collaborative ecosystem among device manufacturers, software developers, and clinical centers, accelerating the adoption of advanced imaging platforms in major hospitals and leading to continuous improvements in patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Interventional Neuroradiology Market Size by Component & CAGR (2026-2033)

• Market Overview
• Embolization Devices
• Neurothrombectomy Devices
• Support Devices
• Access Devices
• Software as a Service Platforms

Global Interventional Neuroradiology Market Size by Pathology Type & CAGR (2026-2033)

• Market Overview
• Intracranial Aneurysms
• Arteriovenous Malformations
• Acute Ischemic Stroke
• Carotid Artery Disease

Global Interventional Neuroradiology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Interventional Neuroradiology Market Size & CAGR (2026-2033)

• North America (Component, Pathology Type, End User)
  • US
  • Canada
• Europe (Component, Pathology Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Pathology Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Pathology Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Pathology Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Coloplast AS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson and Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt USA LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micrus Endovascular Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediview XR Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xironetic Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scopis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Realize Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genesis MedTech International Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations